For citations:
Bonda IA. ADVANTAGES, SAFETY AND PROSPECTS OF SITAGLIPTIN APPLICATION IN TYPE 2 DIABETES MELLITUS WITH CHRONIC KIDNEY DISEASE. Meditsinskiy sovet = Medical Council. 2017;(11):170-175. (In Russ.) https://doi.org/10.21518/2079-701X-2017-11-170-175